This video highlights results of REACT, a phase III multi-center double-blind randomized trial of celecoxib vs placebo in patients with breast cancer.
R. Charles Coombes, MD, PhD
Advertisement
Articles by R. Charles Coombes, MD, PhD
Advertisement
Latest Updated Articles
Could COX-2 Inhibition With Celecoxib Have Role in Breast Cancer?Published: January 8th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Frontline Immunotherapy Improves OS Vs BRAF/MEK Inhibitors in BRAF+ NSCLC
3
FDA Issues CRL for Dasatinib in CML/ALL
4
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
5
